Introduction 74
Lymph node enlargement or lymphadenopathy is often encountered during physical 75 examination in canine patients (Thangapandiyan et al, 2010) . Lymph node enlargement is 76 categorised into solitary (single lymph node), regional (chains of lymphatic nodes draining a 77 specific anatomic region) or generalised (multicentric lymph node enlargement affecting 78 multiple anatomic regions) lymphadenopathy. The causes of lymph node enlargement include 79 oedema, reactive hyperplasia, inflammation, infection and neoplasia (Sapierzynski et al, 80 2009 ). Fine needle aspiration cytology (FNAC) is a valuable diagnostic test to investigate the 81 cause of lymph node enlargement due to its low cost, simplicity and rapid results (Cowell et 82 al, 2003) . 83
The normal cell distribution on cytological evaluation of the lymph node is reported to be 85-84 90% of small lymphocytes, <10% of medium-sized and large lymphocytes, <3% of plasma 85 cells, and rare neutrophils, eosinophils and macrophages (MacNeill, 2011) . 86
Lymphadenitis is defined as an infiltration of one or more non-lymphoid inflammatory cells 87 in a lymph node (Teske, 2014) . Neutrophilic lymphadenitis, also called purulent or 88 suppurative lymphadenitis, is characterised by a neutrophil population exceeding 5% of the 89 cellular population within a lymph node (Raskin et al, 2016) . It may be associated with 90 bacterial, neoplastic or immune-mediated diseases. Granulomatous lymphadenitis is 91 diagnosed when the percentage of histiocytic cells is greater than 2% of the total cell 92 population in a lymph node. Pyogranulomatous lymphadenitis is considered when lymph 93 nodes contain mixed inflammation comprised of increased numbers of neutrophils and 94 macrophages (McNeill, 2011) . Pyogranulomatous lymphadenitis can be associated with 95 fungal, mycobacterial and neorickettsial infections, leishmaniasis, bartonellosis, 96 prothotecosis, juvenile cellulitis, vasculitis and idiopathic lymphadenitis (Ishida, 2017 ; 97 Raskin et al, 2016) . There is a small number of cases reported with sterile lymphadenitis but 98 this disease is currently poorly understood (Day, 1996; Hoffmann et al, 2002) . These cases 99 can often present with pyrexia. 100 101 Pyrexia, or fever, is defined as increased body temperature due to an elevation of the thermal 102 set point in the anterior hypothalamus secondary to pyrogen release (Ramsey et al, 2017) . 103
Fever of unknown origin (FUO) is a major diagnostic challenge in both human and veterinary 104 medicine (Chervier et al, 2012) . Although the human literature is relatively complete 105 regarding FUO, there are few studies in the veterinary literature to explore the more common 106 causes of canine FUO (Battersby et al, 2006; Chervier et al, 2012; Dunn et al, 1998) . 107
The aim of this study was to report the clinical presentation, diagnostic testing, treatment 108 response and outcome of canine sterile steroid-responsive lymphadenitis (CSSRL), which is 109 not well described in the veterinary literature. 110 111 112
Materials and Methods 114
The medical records of dogs diagnosed with canine sterile steroid-responsive lymphadenitis 115 from 2009 to 2016 at six specialist referral centres in the United Kingdom (UK) were 116 retrospectively evaluated. The data from each institution was retrieved via searches of 117 practice management systems with computerised and paper-based records. Collaboration 118 between institutions was achieved by completing a standardised spreadsheet. Data collected 119 included signalment, history (including time to referral and pre-referral treatment), physical 120 examination findings (including lymph node size and distribution), clinical pathology data 121 (including results of lymph node cytology and/or histopathology and infectious disease 122 screening), diagnostic imaging results, treatment and outcome (including time to relapse, 123 repeat treatment). Pyrexia was defined as a temperature >39.2°C. Dogs with incomplete 124 medical records were excluded. The study was approved by the ethics committee of the 125 School of Veterinary Medicine and Science, University of Nottingham. 126 127 Case inclusion criteria required a diagnosis of lymphadenitis either with cytology, 128 histopathology or both in which no underlying cause was identified and a positive response to 129 treatment with glucocorticoids . Dogs that clinically improved on treatment with 130 antimicrobial agents were excluded. When cytology was performed, neutrophilic 131 lymphadenitis was diagnosed when the neutrophil population in the lymph node was >5%; 132 granulomatous lymphadenitis was diagnosed when histiocytic cells comprised >2% of the 133 lymph node population and pyogranulomatous lymphadenitis was diagnosed when there was 134 a mixed inflammatory infiltrate with increased numbers of neutrophils and macrophages 135 within the lymph node; necrotizing lymphadenitis was diagnosed when there was 136 neutrophilic or histiocytic inflammation accompanied by necrosis within the lymph node; 137 reactive hyperplasia was diagnosed when there were increased numbers (15-30%) of medium and large lymphocytes with increased numbers of plasma cells (Raskin, 2016) . When 139 histopathology was performed, the type of lymphadenitis was established based on the 140 predominant cell present, its distribution within the lymph node and the quality and character 141 of the neutrophil nuclei and the presence of granulomas/pyogranulomas (Valli, 2016) . Canine sterile steroid-responsive lymphadenitis was diagnosed in the forty-nine dogs enrolled 168 in this study. These included nineteen different breeds as well as 7 mixed-breed dogs. English 169 Springer spaniels (16/49) were the most common breed followed by cocker spaniels (4/49), 170
Border collies (3/49), German shepherds (2/49) and beagles (2/49). (Table 1) 
171
The median age at presentation was 3 years and 9 months (range 6 months to 10 years). 172
Thirty-one of the dogs were female (62%; 40% neutered) and 18 were male (36%; 18% 173 neutered). There were no significant differences between English springer spaniels and other 174 breeds with regard to age (median 44 months versus 44.7 months) and sex (female 58.8%, 175 60% neutered versus 68.7%; 72.7% neutered). 176
Previous history included idiopathic epilepsy in 2 dogs, intervertebral disc disease in one dog, 177 previous septic peritonitis in one dog, hamartoma in the right hip and otitis in one dog and 178 protein losing nephropathy and spontaneous (resolved) haemothorax in another dog. Arthropod-borne disease testing was performed in 37 of the cases (74%) and of these, 100% 234 of the cases were tested for Borrelia burgdorferi with serology, 34 cases (91.9%) were tested 235 for Bartonella henselae with PCR from blood, 9 cases (24.3%) were tested for Anaplasma 236 phagocytophilum with PCR from blood, 4 cases (10.8%) were tested for Ehrlichia canis with 237 PCR of blood and 1 case (2.7%) was tested for Leishmania infantum with serology. All the 238 results were negative. 239
Arthrocentesis and subsequent synovial fluid cytological analysis and culture was performed 240 in 9 out of 49 cases (18%) as part of a FUO work-up; from which 4 (44.4%) were considered 241 normal, 4 (44.4%) showed marked neutrophilic inflammation and 1 (11.1%) showed mild 242 neutrophilic inflammation. All the cultures were negative. day. Due to the multi centre nature of the study, and the fact that many dogs continued their 304 care at their primary veterinary clinic, 13 dogs were lost to follow-up whilst receiving 305 decreasing doses of prednisolone. Five of 49 dogs had an initial good response to treatment; 306 however they died or were euthanized during or after treatment. The cause of death was 307 unknown in these dogs and no post-mortem examination information was available.. 308 309 Eighteen dogs had a recurrence of their clinical signs during the study period of which 13 310 were springer spaniels. The average time to return of clinical signs was 19 weeks after 311 diagnosis. In 12 of the 18 cases, prednisolone had been withdrawn before the time of 312 recurrence of clinical signs whereas the rest were still on tapering doses of corticosteroids. 313
Two dogs were monitored without adding further treatment and they did not show further 314 progression of signs. Fourteen dogs recommenced increased doses of prednisolone, which 315 resulted in resolution of the clinical signs and the lymphadenopathy. Two other dogs had two 316 episodes of return of clinical signs of which one responded well to re-treatment with 317 prednisolone on each occasion while the other responded well on the first occasion but not 318 the second. In one of the 18 cases with recurrence of clinical signs there was a rapid decrease 319 in prednisolone dose over 3-4 weeks the rest had a reduction over 3-6 months. 320
321
Relating outcome with cytological/histological diagnosis, of the 22 dogs that were clinically 322 well without treatment, 10 had neutrophilic lymphadenitis, 10 had pyogranulomatous 323 lymphadenitis, one had granulomatous lymphadenitis and one had necrotizing lymphadenitis. 324
Of the five cases that were euthanized or died, two had neutrophilic lymphadenitis and three 325 (50%) had pyogranulomatous lymphadenitis. showed no bacterial growth; however, this particular point is difficult to fully characterise, as 350 many animals were pre-treated with antimicrobials, which could preclude the growth or 351 bacterial organisms. On the other hand, the fact that many of these animals were treated with 352 antimicrobials and showed no clinical improvement and responded well to steroid therapy 353 would suggest that an infectious aetiology was unlikely. 354
355
In this UK population of dogs with CSSRL it appears that females were more affected 356 compared to males (31 females and 18 males). This finding is similar to findings in other 357 immune mediated diseases such as IMHA or ITP being also overrepresented in female dogs 358 in some studies (Carr et al, 2002 Median age at initial presentation was 3 years and 9 months, with ages ranging from 6 362 months to 10 years. This is similar to the age incidence of other primary immune mediated 363 diseases, for example IMPA, being more prevalent in young adult dogs (Johnson & Mackin, 364 2012) 365
366
The most frequent clinical signs documented were lethargy, pyrexia and inappetence. In 367 addition, a small number of dogs presented with neck pain and abdominal pain, both of which 368 could account for anorexia. Respiratory signs were present in several cases: 7 animals 369 presented with cough and 2 animals were dyspnoeic. One dog developed severe respiratory 370 complications (acute onset dyspnoea) soon after initiating treatment with corticosteroids but 371 in most of them the thoracic abnormalities resolved after starting treatment. This cause of the 372 respiratory decompensation in this dog remains uncertain, but some of the changes noted 373 could be vasculitis-related or potentially a secondary sequelae of the underlying primary 374 immune-mediated disease process or a pulmonary thromboembolism. Therefore, even if 375 pyrexia, inappetence and lethargy are the most common clinical signs according to the cases 376 studied here, a variety of other clinical signs can be present with this condition. Additionally, 377 concurrent immune mediated conditions such as IMHA, ITP, IMPA and meningitis were 378 detected in 4 individual cases. Lymphadenopathy in these four dogs may be part of a reactive 379 process secondary to these individual primary immune-mediated lymphadenitis or part of a 380 multi-systemic immune mediated condition. This would be further supported by the fact that 381 these dogs had generalized external and even internal lymphadenopathy rather than local 382 lymphadenopathy from the affected areas. These cases did not appear to require higher doses 383 of glucocorticoids in this study population compared with the cases that did not had 384 concurrent diseases. 385 386 Regarding the lymphadenopathy, it was not restricted to peripheral lymph nodes, and in 387 certain cases there were no signs of peripheral lymphadenopathy. From the results we 388 obtained, mandibular, superficial cervical and popliteal lymph nodes were the lymph nodes 389 that were most frequently affected. Also, these are the lymph nodes more readily palpated on general physical examination. Regarding outcome, there was no relationship noted between 391 the number of nodes affected or their location as to outcome or response to treatment. 392
393
In all dogs, a diagnosis of lymphadenitis was reached with lymph node cytology and/or 394 histopathology. Based on cytology, the predominant type of lymphadenitis was neutrophilic, 395
whereas the predominant type of lymphadenitis that was documented from the histopathology 396 samples was pyogranulomatous. The discrepancy between cytology and histopathology may 397 be attributable to the fact that sections obtained for histopathology may have been more 398 representative samples, particularly as they would have preserved the architecture of the 399 lymph node. However, the type of inflammation present did not appear to alter overall 400 outcome for dogs in this study. 401
402
Prednisolone was the first line immunosuppressive treatment chosen for most dogs, of which 403 34 dogs commenced with 1mg/kg dose per day (dose range 0.5-3mg/kg per day). Due to the 404 inherent difficulties with a retrospective study from a multi-centre database, the reasoning for 405 the starting doses and protocol of continuation of treatment was difficult to establish. Forty-406 seven dogs showed marked improvement in clinical condition, decrease in pyrexia and 407 decrease in lymphadenopathy within 12-48 hours of initiation of corticosteroid 408 administration. In six of the cases, CRP concentration was used for monitoring response to 409 the treatment and the values normalised when there was clinical improvement. Animals had 410 previously received intravenous fluid therapy, non-steroidal anti-inflammatories, and 411 antimicrobials of varying classes, all of which had showed minimal improvement and when 412 started on corticosteroids their clinical signs improved dramatically within 12-48 hours. One 413 case initially responded to antimicrobial therapy, but it relapsed four weeks after stopping the 414 therapy, and was subsequently commenced prednisolone therapy, which immediately
